M1I (p.Met1Ile) variant of PCDH19 (Protocadherin-19)

M1I (p.Met1Ile) in PCDH19 (Protocadherin-19) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Developmental and epileptic encephalopathy, 9. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes structural context.

M1I (p.Met1Ile) variant details